Streptozotocin (STZ)-induced diabetes in mice (male BALB/c), upon treatment with Dp (100 mg/ml), in free and liposomal forms for 8 weeks displayed reduction in albumin glycosylation rate, and the data revealed that the liposomal form of Dp could be developed as an effective treatment modality to control diabetes (87). The gene discussed is ALB; the disease is diabetes mellitus.